CME Program Detail

Title: The 8th Annual Stroke and Neurocritical Care Conference 2020 - Two Day Program
Date: Wed, Oct 21st, 2020
Time: 3:00 pm - 7:00 pm
Location: Online

Statement of Need:
In the United States someone has a stroke every 40 seconds, and every 4 minutes someone dies from stroke. Stroke is also a leading cause of serious disability. To adapt to the COVID-19 pandemic and its implications, the 6th Annual Stroke and Neurocritical Care Conference has been transformed into a fully virtual event. Presented by the Department of Neurology and the Department of Neurosurgery, this conference will provide registrants with an excellent, evidence-based educational experience. Broadcast LIVE from NewYork-Presbyterian Queens, speakers will present scientific advances and best practice in stroke care and neurocritical care to optimize successful patient outcomes. Topics will include stroke assessment, therapeutic approaches, controversies and the latest information on Covid-19 cerebrovascular manifestations and management.

Target Audience:
Physicians, fellows, residents, students, physician assistant, nurse practitioners, nurses and other healthcare professionals that care for patients with stroke

Speakers:

Baxter B. Allen, MD
Assistant Professor of Clinical Neurology, Weill Cornell Medicine
Attending Neurointensivist, Department of Neurology, NYP/Queens

Gary L. Bernardini, MD, PhD
Professor and Chair, Department of Neurology, NYP/Queens
Vice Chair, Department of Neurology, Weill Cornell Medicine

Srikanth R. Boddu, MS, MRCS, FRCR, MD
Assistant Professor of Radiology in Neurosurgery, Weill Cornell Medicine
Attending Neurosurgeon, Department of Surgery, NYP/Queens

Ji Y. Chong, MD
Assistant Professor of Clinical Neurology, Weill Cornell Medicine
Assistant Attending Neurologist, NewYork-Presbyterian Hospital

Margaret Huynh, DO
Assistant Professor of Clinical Neurology, Weill Cornell Medicine
Attending Neurointensivist, Department of Neurology, NYP/Queens

Feliks Koyfman, MD
Assistant Professor of Clinical Neurology, Weill Cornell Medicine
Director of Stroke Service, Department of Neurology, NYP/Queens

Ning Lin, MD
Assistant Professor of Neurosurgery, Weill Cornell Medicine
Attending Neurosurgeon, Department of Surgery, NYP/Queens

Alexander E. Merkler, MD
Assistant Professor of Neurology & Neuroscience, Weill Cornell Medicine
Assistant Attending Neurologist, NewYork-Presbyterian Hospital

Neal Parikh, MD
Assistant Professor of Neurology & Neuroscience, Weill Cornell Medicine
Assistant Attending Neurologist, NewYork-Presbyterian Hospital

Candice Perkins, MD
Attending Neurologist
Department of Neurology, NYP/Queens

Kevin N. Sheth, MD
Professor of Neurology and Neurosurgery
Associate Chair for Clinical Research, Department of Neurology
Division Chief, Neurocritical Care & Emergency Neurology
Yale School of Medicine

Jay Yasen, MD
Assistant Professor of Clinical Neurology, Weill Cornell Medicine
Attending Neurologist, Department of Neurology, NYP/Queens
Disclosures: None

Moderators:

Gary L. Bernardini, MD, PhD and Ning Lin, MD

Objectives:

• Specify current management of acute ischemic stroke.
• Identify treatment options for atrial fibrillation.
• Discuss guidelines and observational data for DOAC’s in AF and ICH.
• Describe TIA and minor stroke therapy including dual antiplatelet therapy.
• Review the vascular etiology of vision loss.
• Identify and assess COVID-19 cerebrovascular manifestations.
• Specify treatment of malignant edema from stroke.
• Delineate controversies surrounding mechanical thrombectomy.
• Specify management of pulsatile tinnitus.
• Review recommended preventive and lifestyle changes related to ischemic stroke and TIA.
• Specify etiology, diagnosis and treatment of ICP in the Neuro-ICU.
• Discuss assessment efficacy of rapid response EEG in critical care.

Schedule:

Agenda For Day 1
3:00 - 3:05pm
Introduction
Gary L. Bernardini, MD, PhD

3:05 - 3:40pm
Overview of Acute Ischemic Stroke
Gary L. Bernardini, MD, PhD

3:40 - 4:15pm
Treatment Options for Atrial Fibrillation
Candice Perkins, MD

4:15 - 4:50pm
Reversal and Resumption of DOACs in Atrial Fibrillation and ICH
Feliks Koyfman, MD

4:15 - 5:05pm
Q & A Part I

5:05 - 5:40pm
TIA and Minor Stroke: Update on Management Including Use of Dual Antiplatelet Therapy
Ji Y. Chong, MD

5:40 - 6:15pm
Common Vascular Causes of Vision Loss
Jay Yasen, MD

6:15 - 6:50pm
Cerebrovascular Manifestation of COVID-19
Alexander E. Merkler, MD

6:50 - 7:00pm
Q & A Part II

7:00pm
Adjourn

Agenda For Day 2
3:00 - 3:05pm
Introduction
Gary L. Bernardini, MD, PhD

3:05 - 3:45pm
Malignant Edema from Stroke: Optimal Treatments and Lessons from the GAMES Trial
Kevin N. Sheth, MD

3:45 - 4:20pm
Controversies in Mechanical Thrombectomy
Ning Lin, MD

4:25 - 4:55pm
Endovascular Treatment for Pulsatile Tinnitus
Srikanth R. Boddu, MD

4:55 - 5:05pm
Q & A Part I

5:05 - 5:40pm
Lifestyle Modification for Secondary Prevention after Ischemic Stroke and TIA
Neal Parikh, MD

5:40 - 6:15pm
Elevated ICP in the Neuro-ICU: Etiology, Diagnosis and Treatment
Margaret Huynh, DO

6:15 - 6:50pm
Rapid Response and Critical Care EEG
Baxter B. Allen, MD

6:50 - 7:00pm
Q & A Part II

7:00pm
Adjourn

Accreditation
NewYork Presbyterian/Queens is accredited by the Medical Society of the State of New York (MSSNY) to provide continuing medical education for physicians.

NewYork Presbyterian/Queens designates this Live Activity for a maximum of 8.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement
The Medical Society of The State of New York relies upon planners and faculty participants in its CME activities to provide educational information that is objective and free of bias. In this spirit and in accordance with the guidelines of MSSNY, CPME and the ACCME, all speakers and planners for CME activities must disclose any relevant financial relationships with commercial interests whose products, devices or services may be discussed in the content of a CME activity, that might be perceived as a real or apparent conflict of interest. Any discussion of investigational or unlabeled uses of a product will be identified.

<< Back to Programs List

<< Back to Program Archive